{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:02:03Z","timestamp":1793073723652,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1245\/s10434-022-12753-0","type":"journal-article","created":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T19:02:37Z","timestamp":1667156557000},"page":"1840-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative"],"prefix":"10.1245","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2191-6811","authenticated-orcid":false,"given":"Eliza W.","family":"Beal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengli","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian M.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Pokrzywa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Raoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Leiting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jula","family":"Veerapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anai","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugwuji","family":"Maduekew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishir","family":"Maithel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abdel-Misih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan M.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,30]]},"reference":[{"key":"12753_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ygyno.2018.03.001","volume":"149","author":"JO Schorge","year":"2018","unstructured":"Schorge JO, Bregar AJ, Durfee J, Berkowitz RS. Meigs to modern times: the evolution of debulking surgery in advanced ovarian cancer. Gynecol Oncol. 2018;149:447\u201354.","journal-title":"Gynecol Oncol"},{"key":"12753_CR2","first-page":"18","volume":"7","author":"MG Neuwirth","year":"2016","unstructured":"Neuwirth MG, Alexander HR, Karakousis GC. Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol. 2016;7:18\u201328.","journal-title":"J Gastrointest Oncol"},{"key":"12753_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","volume":"7","author":"RM Van Stein","year":"2021","unstructured":"Van Stein RM, Aalbers AGJ, Sonke GS, Van Driel WJ. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021;7:1231\u20138.","journal-title":"JAMA Oncol"},{"key":"12753_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11605-020-04771-8","volume":"25","author":"MC Morris","year":"2021","unstructured":"Morris MC, Cloyd JM, Hays J, Patel SH. The role of hyperthermic intraperitoneal chemotherapy for non-colorectal peritoneal surface malignancies. J Gastrointest Surg. 2021;25:303\u201318.","journal-title":"J Gastrointest Surg"},{"issue":"4","key":"12753_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-016-5698-x","volume":"24","author":"C Ihemelandu","year":"2017","unstructured":"Ihemelandu C, Sugarbaker PH. Management for peritoneal metastasis of colonic origin: role of cytoreductive surgery and perioperative intraperitoneal chemotherapy: a single institution\u2019s experience during two decades. Ann Surg Oncol. 2017;24(4):898\u2013905.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"12753_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-9","volume":"92","author":"D Elias","year":"2001","unstructured":"Elias D, Blot F, Elotmany A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92(1):71\u20136.","journal-title":"Cancer"},{"key":"12753_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1055-3207(03)00037-1","volume":"12","author":"O Glehen","year":"2003","unstructured":"Glehen O, Gilly FN. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am. 2003;12:649\u201371.","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"12753_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5306\/wjco.v8.i3.266","volume":"8","author":"RLC Araujo","year":"2017","unstructured":"Araujo RLC, Herman P, Riechelmann RP. Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: systematic review. World J Clin Oncol. 2017;8(3):266.","journal-title":"World J Clin Oncol"},{"issue":"8","key":"12753_CR9","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","volume":"22","author":"GA Simkens","year":"2015","unstructured":"Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22(8):2656\u201362.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"12753_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s11605-014-2477-5","volume":"18","author":"P Tabrizian","year":"2014","unstructured":"Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18(5):1024\u201331.","journal-title":"J Gastrointest Surg."},{"issue":"13","key":"12753_CR11","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1245\/s10434-020-08843-6","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, et al. Implications of postoperative complications for survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol. 2020;27(13):4980\u201395.","journal-title":"Ann Surg Oncol"},{"key":"12753_CR12","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ejso.2015.05.018","volume":"41","author":"TR Van Oudheusden","year":"2015","unstructured":"Van Oudheusden TR, Nienhuijs SW, Luyer MD, Nieuwenhuijzen GA, Lemmens VE, Rutten HJ, et al. Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: a systematic review. Eur J Surg Oncol. 2015;41:1269\u201377.","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"12753_CR13","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/cncr.28273","volume":"119","author":"EC Zabor","year":"2013","unstructured":"Zabor EC, Gonen M, Chapman PB, Panageas KS. Dynamic prognostication using conditional survival estimates. Cancer. 2013;119(20):3589\u201392.","journal-title":"Cancer"},{"issue":"8","key":"12753_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1634\/theoncologist.2009-0211","volume":"15","author":"RM Merrill","year":"2010","unstructured":"Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist. 2010;15(8):873\u201382.","journal-title":"Oncologist"},{"issue":"2","key":"12753_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1245\/s10434-015-4821-8","volume":"23","author":"HD Mogal","year":"2016","unstructured":"Mogal HD, Levine EA, Russell G, Shen P, Stewart JH, Votanopoulos KI. Conditional survival after cytoreductive surgery with heated intraperitoneal chemotherapy for low- and high-grade appendiceal primaries. Ann Surg Oncol. 2016;23(2):534\u20138.","journal-title":"Ann Surg Oncol"},{"key":"12753_CR16","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.amjsurg.2019.09.017","volume":"219","author":"EW Beal","year":"2020","unstructured":"Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, et al. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020;219:478\u201383.","journal-title":"Am J Surg"},{"key":"12753_CR17","doi-asserted-by":"publisher","first-page":"101492","DOI":"10.1016\/j.suronc.2020.11.006","volume":"37","author":"JT Wiseman","year":"2021","unstructured":"Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, et al. A multi-institutional analysis of textbook outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol. 2021;37:101492.","journal-title":"Surg Oncol"},{"issue":"4","key":"12753_CR18","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1245\/s10434-021-10994-z","volume":"29","author":"AA Memon","year":"2022","unstructured":"Memon AA, Godbole C, Cecil T, Dayal S, Moran B, Tzivanakis A, et al. Overall survival is more closely associated with peritoneal than primary appendiceal pathological grade in pseudomyxoma peritonei with discordant pathology. Ann Surg Oncol. 2022;29(4):2607\u201313. https:\/\/doi.org\/10.1245\/s10434-021-10994-z.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"12753_CR19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jso.26099","volume":"122","author":"OS Eng","year":"2020","unstructured":"Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, et al. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an opportunity for enhanced recovery pathways. J Surg Oncol. 2020;122(5):980\u20135.","journal-title":"J Surg Oncol"},{"issue":"7","key":"12753_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.4251\/wjgo.v12.i7.756","volume":"12","author":"JL Leiting","year":"2020","unstructured":"Leiting JL, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dessureault S, et al. Comparison of open and closed hyperthermic intraperitoneal chemotherapy: results from the United States hyperthermic intraperitoneal chemotherapy collaborative. World J Gastrointest Oncol. 2020;12(7):756\u201367.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"12753_CR21","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1080\/02656736.2020.1819571","volume":"37","author":"JL Leiting","year":"2020","unstructured":"Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, et al. The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia. 2020;37(1):1182\u20138.","journal-title":"Int J Hyperthermia"},{"issue":"1","key":"12753_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, et al. Optimal surveillance frequency after CRS\/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol. 2020;27(1):134\u201346.","journal-title":"Ann Surg Oncol."},{"key":"12753_CR23","unstructured":"R Core Team. European Environment Agency; 2020."},{"issue":"4","key":"12753_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1245\/s10434-017-6305-5","volume":"25","author":"M Guaglio","year":"2018","unstructured":"Guaglio M, Sinukumar S, Kusamura S, Milione M, Pietrantonio F, Battaglia L, et al. Clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol. 2018;25(4):878\u201384.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"12753_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","volume":"24","author":"NC Levinsky","year":"2020","unstructured":"Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, et al. Should we be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC Collaborative. J Gastrointest Surg. 2020;24(1):155\u201364.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"12753_CR26","doi-asserted-by":"publisher","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","volume":"2","author":"JM Foster","year":"2019","unstructured":"Foster JM, Sleightholm R, Patel A, Shostrom V, Hall B, Neilsen B, et al. Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open. 2019;2(1):e186847\u2013e186847.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"12753_CR27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1158\/1078-0432.CCR-14-2154","volume":"21","author":"S Hieke","year":"2015","unstructured":"Hieke S, Kleber M, K\u00f6nig C, Engelhardt M, Schumacher M. Conditional survival: a useful concept to provide information on how prognosis evolves over time. Clin Cancer Res. 2015;21(7):1530\u20136.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"12753_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1378\/chest.116.3.697","volume":"116","author":"RM Merrill","year":"1999","unstructured":"Merrill RM, Henson DE, Barnes M. Conditional survival among patients with carcinoma of the lung. Chest. 1999;116(3):697\u2013703.","journal-title":"Chest"},{"key":"12753_CR29","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s11605-020-04897-9","volume":"25","author":"T Michelakos","year":"2021","unstructured":"Michelakos T, Sekigami Y, Kontos F, Fern\u00e1ndez-del Castillo C, Qadan M, Deshpande V, et al. Conditional survival in resected pancreatic ductal adenocarcinoma patients treated with total neoadjuvant therapy. J Gastrointest Surg. 2021;25:2859\u201370.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"12753_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cas.14231","volume":"111","author":"QY Chen","year":"2020","unstructured":"Chen QY, Zhong Q, Zhou JF, Qiu XT, Dang XY, Cai LS, et al. Conditional survival and recurrence of remnant gastric cancer after surgical resection: a multi-institutional study. Cancer Sci. 2020;111(2):502\u201312.","journal-title":"Cancer Sci"},{"issue":"7","key":"12753_CR31","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1245\/s10434-016-5105-7","volume":"23","author":"Y Sekigami","year":"2016","unstructured":"Sekigami Y, Rajeev R, Johnston F, Clark Gamblin T, Turaga KK. Conditional survival as a patient centered metric for patients with appendiceal adenocarcinoma. Ann Surg Oncol. 2016;23(7):2295\u2013301.","journal-title":"Ann Surg Oncol"},{"issue":"36","key":"12753_CR32","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1200\/JCO.2014.55.1713","volume":"32","author":"ML Kurta","year":"2014","unstructured":"Kurta ML, Edwards RP, Moysich KB, McDonough K, Bertolet M, Weissfeld JL, et al. Prognosis and conditional disease-free survival among patients with ovarian cancer. J Clin Oncol. 2014;32(36):4102\u201312.","journal-title":"J Clin Oncol"},{"key":"12753_CR33","first-page":"1","volume":"42","author":"CD Bergerot","year":"2022","unstructured":"Bergerot CD, Philip EJ, Bergerot PG, Siddiq N, Tinianov S, Lustberg M. Fear of cancer recurrence or progression: What is it and what can we do about it? Am Soc Clin Oncol Educ Book. 2022;42:1\u201310.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"12753_CR34","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1200\/OP.20.00799","volume":"17","author":"J Liu","year":"2021","unstructured":"Liu J, Butow P, Bui KT, Serafimovska A, Costa DSJ, Kiely BE, et al. Novel clinician-lead intervention to address fear of cancer recurrence in breast cancer survivors. J Oncol Pract. 2021;17(6):e774\u201384.","journal-title":"J Oncol Pract"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12753-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-12753-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-12753-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T20:16:29Z","timestamp":1701288989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-12753-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,30]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["12753"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-12753-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,30]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.D.\u2014Equity in Doximity in the last year.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}